These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 9450167)

  • 61. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
    Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F
    Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [TBL] [Abstract][Full Text] [Related]  

  • 63. General pharmacological properties of Sho-seiryu-to (TJ-19) extracts.
    Amagaya S; Iizuka A; Makino B; Kubo M; Komatsu Y; Cheng FC; Ruo TI; Itoh T; Terasawa K
    Phytomedicine; 2001 Sep; 8(5):338-47. PubMed ID: 11695876
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 65. General pharmacology of a Pseudomonas vaccine prepared from outer-membrane fractions of Pseudomonas aeruginosa.
    Park WJ; Kim YH; Jeong SM; Park KH; Kim HS; Kim YS; Hahm KS; Munt PL; Algate DR
    Arzneimittelforschung; 1996 Oct; 46(10):1001-6. PubMed ID: 8931896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 68. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
    Leonardi A; Guarneri L; Poggesi E; Angelico P; Velasco C; Cilia A; Testa R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1027-37. PubMed ID: 11714892
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
    Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
    Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [General pharmacology of T-2588, a new oral cephem antibiotic].
    Hirai S; Kodama T; Hiraiwa T; Abe N; Arai H; Ono S; Omori M; Nakada Y; Hashiba K; Tanada K
    Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [General pharmacology of T-1982, a new cephamycin antibiotic].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Arai H; Omori M; Tanada K; Senda N; Hashiba K; Matsukura K; Takata K; Okami H
    Jpn J Antibiot; 1982 Sep; 35(9):2139-54. PubMed ID: 7143714
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacological activities and side effects of plafibride.
    Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [General pharmacological studies on tramadol, a potent analgetic agent (author's transl)].
    Osterloh G; Friderichs E; Felgenhauer F; Günzler WA; Henmi Z; Kitano T; Nakamura M; Hayashi H; Ishii I
    Arzneimittelforschung; 1978; 28(1a):135-51. PubMed ID: 305247
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
    Tsubo K; Arai M; Omachi H; Mitamura K
    J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pharmacological investigations with the combination sulfamoxole/trimethoprim, a new broadspectrum chemotherapeutic agent (author's transl)].
    Gries J; Kretzschmar R; Kuhne J; Neumann W; Osterloh G; Scherschlicht R; Worstmann W
    Arzneimittelforschung; 1976; 26(42):623-33. PubMed ID: 947323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
    Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1987 Jun; 37(6):703-7. PubMed ID: 3663268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological studies on taurohyodeoxycholic acid.
    Tripodi AS; Contos S; Germogli R
    Arzneimittelforschung; 1993 Aug; 43(8):877-80. PubMed ID: 8216446
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gastrointestinal prokinetic and antiemetic effects of a new substituted pyrimidinO 6553 (2-methylamino-4-N-methylpiperazino-5-thiomethyl-6-chloropyrimidine hydrochloride).
    Loiseau G; Millischer R; Donadieu AM; Marquet JP
    Arzneimittelforschung; 1977; 27(3):606-11. PubMed ID: 577427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.